Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
By Lauren Berg · February 1, 2022, 10:41 PM EST
A New York federal judge Monday tossed Regeneron Pharmaceuticals' antitrust lawsuit brought against rival Novartis Pharmaceuticals in response to Novartis' lawsuit claiming Regeneron infringed its patent related to a prefilled syringe...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login